Literature DB >> 11985462

Nanomolar inhibitors of Staphylococcus aureus methionyl tRNA synthetase with potent antibacterial activity against gram-positive pathogens.

Richard L Jarvest, John M Berge, Valerie Berry, Helen F Boyd, Murray J Brown, John S Elder, Andrew K Forrest, Andrew P Fosberry, Daniel R Gentry, Martin J Hibbs, Deborah D Jaworski, Peter J O'Hanlon, Andrew J Pope, Stephen Rittenhouse, Robert J Sheppard, Courtney Slater-Radosti, Angela Worby.   

Abstract

Potent nanomolar inhibitors of Staphylococcus aureus methionyl tRNA synthetase have been derived from a file compound high throughput screening hit. Optimized compounds show excellent antibacterial activity against staphylococcal and enterococcal pathogens, including strains resistant to clinical antibiotics. Compound 11 demonstrated in vivo efficacy in an S. aureus rat abscess infection model.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11985462     DOI: 10.1021/jm025502x

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  37 in total

1.  Urea-based inhibitors of Trypanosoma brucei methionyl-tRNA synthetase: selectivity and in vivo characterization.

Authors:  Sayaka Shibata; J Robert Gillespie; Ranae M Ranade; Cho Yeow Koh; Jessica E Kim; Joy U Laydbak; Frank H Zucker; Wim G J Hol; Christophe L M J Verlinde; Frederick S Buckner; Erkang Fan
Journal:  J Med Chem       Date:  2012-07-11       Impact factor: 7.446

Review 2.  Prospects for aminoacyl-tRNA synthetase inhibitors as new antimicrobial agents.

Authors:  Julian Gregston Hurdle; Alexander John O'Neill; Ian Chopra
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

3.  Selective inhibitors of methionyl-tRNA synthetase have potent activity against Trypanosoma brucei Infection in Mice.

Authors:  Sayaka Shibata; J Robert Gillespie; Angela M Kelley; Alberto J Napuli; Zhongsheng Zhang; Kuzma V Kovzun; Ranae M Pefley; Jocelyn Lam; Frank H Zucker; Wesley C Van Voorhis; Ethan A Merritt; Wim G J Hol; Christophe L M J Verlinde; Erkang Fan; Frederick S Buckner
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

4.  Crystallization of Mycobacterium smegmatis methionyl-tRNA synthetase in the presence of methionine and adenosine.

Authors:  Henrik Ingvarsson; T Alwyn Jones; Torsten Unge
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-05-22

5.  Inhibition of methionyl-tRNA synthetase by REP8839 and effects of resistance mutations on enzyme activity.

Authors:  Louis S Green; James M Bullard; Wendy Ribble; Frank Dean; David F Ayers; Urs A Ochsner; Nebojsa Janjic; Thale C Jarvis
Journal:  Antimicrob Agents Chemother       Date:  2008-11-17       Impact factor: 5.191

6.  A homology model for Clostridium difficile methionyl tRNA synthetase: active site analysis and docking interactions.

Authors:  Ehab Al-Moubarak; Claire Simons
Journal:  J Mol Model       Date:  2010-11-02       Impact factor: 1.810

Review 7.  Challenges of antibacterial discovery.

Authors:  Lynn L Silver
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 8.  Progress and challenges in aminoacyl-tRNA synthetase-based therapeutics.

Authors:  Christopher S Francklyn; Patrick Mullen
Journal:  J Biol Chem       Date:  2019-01-22       Impact factor: 5.157

9.  Inhibition of protein synthesis and malaria parasite development by drug targeting of methionyl-tRNA synthetases.

Authors:  Tahir Hussain; Manickam Yogavel; Amit Sharma
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

10.  Distinct states of methionyl-tRNA synthetase indicate inhibitor binding by conformational selection.

Authors:  Cho Yeow Koh; Jessica E Kim; Sayaka Shibata; Ranae M Ranade; Mingyan Yu; Jiyun Liu; J Robert Gillespie; Frederick S Buckner; Christophe L M J Verlinde; Erkang Fan; Wim G J Hol
Journal:  Structure       Date:  2012-08-16       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.